{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:30Z","timestamp":1787009070402,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>For the past 60\u2009years, benzodiazepines such as chlordiazepoxide, diazepam, and alprazolam have been used as pharmaceutical medications for the treatment of myriad conditions including anxiety, seizures, and insomnia. In more recent years, novel benzodiazepine derivatives have emerged as illicit substances in powders and counterfeit tablets on the illicit drug market. In 2016, bromazolam, a brominated derivative of alprazolam, emerged on the illicit drug market in Europe, but the substance was not reported in the USA until 2019\u20132020. In this study, we report the emergence and subsequent prevalence of bromazolam in postmortem blood in the state of Indiana during 2023. Analysis was completed by a solvent protein precipitation extraction with acetonitrile and detection by liquid chromatography with quadrupole time of flight mass spectrometry. During 2023, bromazolam was detected in 94 cases across 25 counties in Indiana. It was never the sole substance detected and was commonly detected alongside fentanyl (83 cases), norfentanyl (77 cases), 4-anilino-N-phenethylpiperidine (76 cases), acetylfentanyl (49 cases), methamphetamine (32 cases), naloxone (25 cases), 11-nor-9-carboxy-tetrahydrocannabinol (24 cases), and benzoylecgonine (20 cases). After official query with the Indiana Department of Health, it was found that bromazolam was specifically included in the cause of death certification in 31 fatalities (32.9%). Due to the scarcity of information regarding this novel benzodiazepine derivative in postmortem toxicology and its involvement in fatalities, it is important that forensic toxicology laboratories consider adding bromazolam to their comprehensive scope of analysis.<\/jats:p>","DOI":"10.1093\/jat\/bkae053","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T01:30:03Z","timestamp":1717983003000},"page":"582-590","source":"Crossref","is-referenced-by-count":8,"title":["Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023)"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2737-4623","authenticated-orcid":false,"given":"Kevin G","family":"Shanks","sequence":"first","affiliation":[{"name":"Axis Forensic Toxicology , 5780 W. 71st Street, Indianapolis, IN 46268,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.K","family":"Kurtz","sequence":"additional","affiliation":[{"name":"Axis Forensic Toxicology , 5780 W. 71st Street, Indianapolis, IN 46268,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7623-0107","authenticated-orcid":false,"given":"George S","family":"Behonick","sequence":"additional","affiliation":[{"name":"Axis Forensic Toxicology , 5780 W. 71st Street, Indianapolis, IN 46268,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"2024110407421858000_R1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14060560","article-title":"Designer benzodiazepines: a review of toxicology and public health risks","volume":"14","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2024110407421858000_R2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmacy6020043","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training, and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy"},{"key":"2024110407421858000_R3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"key":"2024110407421858000_R4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test Anal"},{"key":"2024110407421858000_R5","article-title":"UNODC. World Drug Report 2019 \u2013 Booklet 3: Depressants","author":"United Nations Office on Drugs and Crime","year":"2019"},{"key":"2024110407421858000_R6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/430248","article-title":"A review of the updated pharmacophore for the alpha 5 GABA(A) benzodiazepine receptor model","volume":"2015","author":"Clayton","year":"2015","journal-title":"Int J Med Chem"},{"key":"2024110407421858000_R7","article-title":"EMCDDA \u2013 Europol 2016 Annual Report on the Implementation of Council Decision 2005\/387\/JHA","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"2024110407421858000_R8","article-title":"National Forensic Laboratory Information System: 2018 Annual Report","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2018"},{"key":"2024110407421858000_R9","article-title":"National Forensic Laboratory Information System: 2019 Annual Report","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2019"},{"key":"2024110407421858000_R10","article-title":"National Forensic Laboratory Information System: 2020 Annual Report","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2020"},{"key":"2024110407421858000_R11","article-title":"National Forensic Laboratory Information System: 2021 Annual Report","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2021"},{"key":"2024110407421858000_R12","article-title":"National Forensic Laboratory Information System: 2022 Annual Report","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2022"},{"key":"2024110407421858000_R13","article-title":"National Forensic Laboratory Information System: June 2023 Drug Snapshot","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2023"},{"key":"2024110407421858000_R14","article-title":"Code of Virginia","volume-title":"Chapter 34. Drug Control Act. 54.1.3446. Schedule I","year":"2023"},{"key":"2024110407421858000_R15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.15585\/mmwr.mm725253a5","article-title":"Notes from the field: seizures, hyperthermia, and myocardial injury in three young adults who consumed bromazolam disguised as alprazolam \u2013 Chicago, Illinois, February 2023","volume":"72","author":"Ehler","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024110407421858000_R16","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.21cr03119","article-title":"Phenibut and bromazolam use disorders requiring hospitalization for medically supervised withdrawal","volume":"24","author":"McDermott","year":"2022","journal-title":"Prim Care Companion CNS Disord"},{"key":"2024110407421858000_R17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jat\/bkad036","article-title":"Increasing prevalence of designer benzodiazepines in impaired driving: a 5-year analysis form 2017 to 2021","volume":"47","author":"Papsun","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2024110407421858000_R18","article-title":"Bromazolam Prevalence Surging Across the United States Driven in Part by Increasing Detection Alongside Fentanyl","author":"Papsun","year":"2022"},{"key":"2024110407421858000_R19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in postmortem cases \u2013 a British Columbia perspective","volume":"47","author":"Merette","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2024110407421858000_R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2023.111891","article-title":"Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales","volume":"354","author":"Hikin","year":"2024","journal-title":"Forensic Sci Int"},{"key":"2024110407421858000_R21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/jat\/bkaa161","article-title":"Flubromazolam-derived designer benzodiazepines: toxicokinetics and analytical toxicology of clobromazolam and bromazolam","volume":"45","author":"Wagmann","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2024110407421858000_R22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","article-title":"Overdose of etizolam: the abuse and rise of a benzodiazepine analog","volume":"65","author":"O\u2019Connell","year":"2015","journal-title":"Ann Emerg Med"},{"key":"2024110407421858000_R23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.forsciint.2019.05.018","article-title":"Is etizolam a safe medication? Effects on psychomotor performance at therapeutic dosages of a newly abuse psychoactive substance","volume":"301","author":"Busardo","year":"2019","journal-title":"Forensic Sci Int"},{"key":"2024110407421858000_R24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jpeds.2020.12.075","article-title":"Pressed etizolam","volume":"232","author":"Love","year":"2020","journal-title":"J Pediatr"},{"key":"2024110407421858000_R25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1017\/cem.2020.417","article-title":"Etizolam overdose in an eight-year-old boy","volume":"22","author":"Khakh","year":"2020","journal-title":"Can J Emerg Manag"},{"key":"2024110407421858000_R26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2020.601827","article-title":"High-dose dependence and cognitive side effects to medical prescription of etizolam","volume":"11","author":"Tamburin","year":"2020","journal-title":"Front Psychiatry"},{"key":"2024110407421858000_R27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/0025802420973814","article-title":"Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases","volume":"61","author":"Hikin","year":"2021","journal-title":"Med Sci Law"},{"key":"2024110407421858000_R28","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/jat\/bkaa146","article-title":"A case series of etizolam in opioid-related deaths","volume":"45","author":"Gevorkyan","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2024110407421858000_R29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jat\/bkaa050","article-title":"Driving impairment cases involving etizolam and flubromazolam","volume":"45","author":"Rohrig","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2024110407421858000_R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2022.111324","article-title":"Toxicity of designer benzodiazepines: a case of etizolam and cocaine intoxication","volume":"336","author":"Drevin","year":"2022","journal-title":"Forensic Sci Int"},{"key":"2024110407421858000_R31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jat\/bkab106","article-title":"Etizolam blood concentrations in 191 forensic cases in Ontario, Canada (2019\u20132020)","volume":"46","author":"Watts","year":"2022","journal-title":"J Anal Toxicol"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkae053\/58277477\/bkae053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/48\/8\/582\/60385592\/bkae053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/48\/8\/582\/60385592\/bkae053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T02:42:27Z","timestamp":1730688147000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/48\/8\/582\/7696179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,6,11]]},"published-print":{"date-parts":[[2024,10,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkae053","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,11]]}}}